摘要
多发性硬化是以中枢神经系统白质脱髓鞘为主要病变特点的自身免疫性疾病.该病好发于青壮年,是非外伤原因导致神经功能残疾较常见的疾病.目前常规治疗还不能有效缓解疾病症状、控制其复发和进展.近年来,随着对MS基础和临床实验研究的日益增多,开发新的有效药物和提高MS的治疗效果逐渐成为世界性的研究热点,药物研究在MS的治疗方向上已取得了良好的实验结果或临床治疗效果.
Multiple sclerosis is a congenital-immune disease which has the main pathological changes characteristics of CNS＇s white matter demyelination. The disease often occurs in the youth and is a common disease of nervous system＇s disability resulting from non-injured causes. At present, the conventional treatment still can＇t lyses the symptom and controls its process and relapse. With the increasingly scientific and clinical research of MS in recent years, it has gradually become a research focus to explore the effective medicine and improve the therapeutic effect. The medical research has made a good experimental result and had the clinical therapeutic effect concerning the MS treatment. This thesis will summarize the research achievements in the MS medical treatment in recent years.
出处
《山西大同大学学报（自然科学版）》
2009年第3期40-44,共5页
Journal of Shanxi Datong University(Natural Science Edition)
基金
国家人事部留学回国人员科技活动择优资助项目[2006-164]
山西省留学回国人员科技活动择优资助项目[2007-50]
山西省大同市2005年科技发展计划项目[2005-81]
关键词
多发性硬化
治疗
免疫调节
抗氧化
multiple sclerosistherapy
therapy
immunity adjustment
anti-oxidate
